323PSubcutaneous trastuzumab (H SC) with intravenous pertuzumab (P IV) and docetaxel (D IV) in HER2-positive advanced breast cancer (BC): MetaPHER second interim analysis.
Saved in:
| Title: | 323PSubcutaneous trastuzumab (H SC) with intravenous pertuzumab (P IV) and docetaxel (D IV) in HER2-positive advanced breast cancer (BC): MetaPHER second interim analysis. |
|---|---|
| Authors: | Kümmel, S1 (AUTHOR), Tondini, C A2 (AUTHOR), Abraham, J3 (AUTHOR), Nowecki, Z I4 (AUTHOR), Itrych, B5 (AUTHOR), Hitre, E6 (AUTHOR), Karaszewska, B7 (AUTHOR), Juarez, A8 (AUTHOR), Morales-Vásquez, F9 (AUTHOR), García, J M Pérez10 (AUTHOR) |
| Source: | Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 133286144 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 323PSubcutaneous trastuzumab (H SC) with intravenous pertuzumab (P IV) and docetaxel (D IV) in HER2-positive advanced breast cancer (BC): MetaPHER second interim analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Kümmel%2C+S%22">Kümmel, S</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tondini%2C+C+A%22">Tondini, C A</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abraham%2C+J%22">Abraham, J</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nowecki%2C+Z+I%22">Nowecki, Z I</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Itrych%2C+B%22">Itrych, B</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hitre%2C+E%22">Hitre, E</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Karaszewska%2C+B%22">Karaszewska, B</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Juarez%2C+A%22">Juarez, A</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Morales-Vásquez%2C+F%22">Morales-Vásquez, F</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22García%2C+J+M+Pérez%22">García, J M Pérez</searchLink><relatesTo>10</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=133286144 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdy272.313 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: N.PAG Titles: – TitleFull: 323PSubcutaneous trastuzumab (H SC) with intravenous pertuzumab (P IV) and docetaxel (D IV) in HER2-positive advanced breast cancer (BC): MetaPHER second interim analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kümmel, S – PersonEntity: Name: NameFull: Tondini, C A – PersonEntity: Name: NameFull: Abraham, J – PersonEntity: Name: NameFull: Nowecki, Z I – PersonEntity: Name: NameFull: Itrych, B – PersonEntity: Name: NameFull: Hitre, E – PersonEntity: Name: NameFull: Karaszewska, B – PersonEntity: Name: NameFull: Juarez, A – PersonEntity: Name: NameFull: Morales-Vásquez, F – PersonEntity: Name: NameFull: García, J M Pérez IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 10 Text: 2018 Supplement Type: published Y: 2018 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 29 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
